Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteitis pubis: a review

S S Lentz1

  • 1Department of Obstetrics and Gynecology, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC 27157, USA.

Obstetrical & Gynecological Survey
|April 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phase I trial of ifosfamide and 24-h infusional paclitaxel in pelvic malignancies: a Gynecologic Oncology Group study.

Gynecologic oncology·2001
Same author

Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study.

International journal of radiation oncology, biology, physics·2000
Same author

A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study.

Gynecologic oncology·2000
Same author

Topotecan has substantial antitumor activity as first-line salvage therapy in platinum-sensitive epithelial ovarian carcinoma: A Gynecologic Oncology Group Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
Same author

Intraperitoneal interferon-alpha in residual ovarian carcinoma: a phase II gynecologic oncology group study.

Gynecologic oncology·1999
Same author

A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group Study.

Gynecologic oncology·1999

Osteitis pubis is a painful inflammatory condition affecting the pubic bone and surrounding areas, often linked to surgical procedures or athletic injuries. It is a self-limiting condition treated with anti-inflammatory agents and rest.

Area of Science:

  • Medical Science
  • Orthopedics
  • Rheumatology

Background:

  • Osteitis pubis is a noninfectious inflammatory condition affecting the pubic symphysis and surrounding structures.
  • It can arise after urologic, obstetrical, and gynecological procedures, with an incidence of 2-3% after Marshall-Marchetti-Krantz urethropexy.
  • Periosteal trauma is considered a key initiating factor, though the exact pathogenesis remains unclear.

Purpose of the Study:

  • To describe osteitis pubis as a clinical entity.
  • To highlight its association with various procedures and athletic activities.
  • To discuss its diagnosis, differential diagnosis, and treatment.

Main Methods:

  • Literature review and clinical description of osteitis pubis.
  • Analysis of symptoms, radiographic findings, and laboratory results.

Related Experiment Videos

  • Discussion of differential diagnoses, particularly osteomyelitis.

    • Main Results:

    • Primary symptom is pain, often with difficulty ambulating and a characteristic waddling gait.
    • Low-grade fever, elevated sedimentation rate, and mild leukocytosis may be present.
    • Radiographic changes appear approximately 4 weeks after symptom onset.

    Conclusions:

    • Osteitis pubis is a distinct clinical entity, differentiated from osteomyelitis by its self-limiting nature and response to nonantibiotic therapy.
    • Treatment involves anti-inflammatory agents and rest for minor cases, with systemic steroids or surgery for recalcitrant cases.
    • The condition should be considered in patients with pelvic pain, especially following trauma to the symphysis pubis or in athletes.